We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

9 hedge funds and large institutions have $18.3M invested in Apollo Endosurgery, Inc. in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,227% more capital invested

Capital invested by funds: $250K → $18.3M (+$18.1M)

10% less funds holding

Funds holding: 109 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q4 2016 in Review

9 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2016, worth a combined $18.3M — up 7,227% from $250K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of APEN and 4 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $22.2M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $173K sold.

  • 9 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2016, down from 10 in Q3 2016.
  • Funds reported $18.3M of Apollo Endosurgery, Inc. stock for Q4 2016, up 7,227% quarter-over-quarter.
  • 4 funds opened new Apollo Endosurgery, Inc. positions in Q4 2016 and 5 closed out, a net change of -1 holder.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2016 was Novo Holdings A/S, an estimated $22.2M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2016 was Renaissance Technologies, an estimated $173K sold.

Based on aggregated 13F filings for Q4 2016.